GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Earnings per Share (Diluted)

Precision BioSciences (FRA:PBS0) Earnings per Share (Diluted) : €-6.80 (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Earnings per Share (Diluted)?

Precision BioSciences's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €1.56. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-6.80.

Precision BioSciences's EPS (Basic) for the three months ended in Mar. 2024 was €1.56. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was €-6.80.

Precision BioSciences's EPS without NRI for the three months ended in Mar. 2024 was €0.47. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was €-8.51.

During the past 3 years, the average EPS without NRIGrowth Rate was 43.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.10% per year.

During the past 7 years, Precision BioSciences's highest 3-Year average EPS without NRI Growth Rate was 43.60% per year. The lowest was -49.70% per year. And the median was 21.35% per year.


Precision BioSciences Earnings per Share (Diluted) Historical Data

The historical data trend for Precision BioSciences's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Earnings per Share (Diluted) Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial -59.67 -51.54 -13.81 -35.97 -14.64

Precision BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.30 -2.77 -1.97 -3.63 1.56

Competitive Comparison of Precision BioSciences's Earnings per Share (Diluted)

For the Biotechnology subindustry, Precision BioSciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precision BioSciences's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's PE Ratio falls into.



Precision BioSciences Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Precision BioSciences's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-56.23-0)/3.841
=-14.64

Precision BioSciences's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(7.901-0)/5.063
=1.56

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Precision BioSciences  (FRA:PBS0) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Precision BioSciences Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Precision BioSciences (FRA:PBS0) Business Description

Traded in Other Exchanges
Address
302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines